Pennside Partners is a leading healthcare consulting firm serving the pharmaceutical, biotechnology, and medical device sectors across the world for more than 25 years. We offer a valuable range of strategic services including launch planning, competitive benchmarking, market assessment, business development, reimbursement, generics and biosimilars studies, licensing and acquisition support, competitive intelligence, qualitative market research, medical congress coverage, and technology / pipeline analysis.
We have extensive project experience and expertise in all major disease areas including oncology, respiratory, cardiovascular, CNS, rheumatology, and dermatology. We have extensive in-house knowledge of new drug development in chemotherapy, targeted therapies, monoclonal antibodies, vaccines, and drug delivery. Pennside’s multidisciplinary teams conduct in-depth primary field research supported by extensive review and analysis of existing data, information and knowledge to provide custom projects that meet our client’s specific needs.
Pennside has offices in the United States, United Kingdom, and Switzerland.
For more information, visit our website at www.pennside.com.